Nature Reviews Cardiology 14, 133–144 (2017)
In the version of this article initially published online and in print, there were some inaccuracies in Table 1. These errors have been corrected for the HTML and PDF versions of the article.
Additional information
The online version of the original article can be found at 10.1038/nrcardio.2016.185
Rights and permissions
About this article
Cite this article
Ruparelia, N., Chai, J., Fisher, E. et al. Erratum: Inflammatory processes in cardiovascular disease: a route to targeted therapies. Nat Rev Cardiol 14, 314 (2017). https://doi.org/10.1038/nrcardio.2017.33
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2017.33
This article is cited by
-
Emerging applications of single-cell profiling in precision medicine of atherosclerosis
Journal of Translational Medicine (2024)
-
Reversal of aging-associated increase in myelopoiesis and expression of alarmins by angiotensin-(1–7)
Scientific Reports (2023)
-
Multi-proteomic Biomarker Risk Scores for Predicting Risk and Guiding Therapy in Patients with Coronary Artery Disease
Current Cardiology Reports (2023)
-
The neutrophil percentage-to-albumin ratio is associated with all-cause mortality in critically ill patients with acute myocardial infarction
BMC Cardiovascular Disorders (2022)
-
Upregulated anti-angiogenic miR-424-5p in type 1 diabetes (model of subclinical cardiovascular disease) correlates with endothelial progenitor cells, CXCR1/2 and other parameters of vascular health
Stem Cell Research & Therapy (2021)
